The reverse hybrid method (also known as "inverse hybrid") uses a cemented all-polyethylene cup in combination with an uncemented stem. This method is partly based on good clinical results of cemented cups and of some uncemented stems in the Norwegian Arthroplasty Register (NAR) ([@CIT0013],[@CIT0014], [@CIT0010]). The register has also shown that some uncemented femoral stems may have better long--term results (\> 10 years) than cemented stems in patients 60 years of age or younger. Based on these findings, the NAR suggested 10 years ago that the use of cemented cups in combination with uncemented stems might be justified in young patients ([@CIT0013]). In the Swedish Hip Arthroplasty Register, the performance of uncemented THR was found to be inferior to that of cemented THR ([@CIT0009]). The authors of that study found that cemented cups performed better than uncemented cups and that uncemented femoral stems had better survival than cemented stems, with aseptic loosening as endpoint. In the Finnish Arthroplasty Registry, [@CIT0018] found better long-term survival regarding aseptic loosening for the best performing types of cementless stems compared to the cemented reference group, in the age group 55--74 years.

McNally et al. (2000) studied survival of the Furlong HA coated femoral stem in combination with a cemented ultra-high-density polyethylene cup at 10--11 years, and found values of 99% for the stem and 95% for the cup. [@CIT0001] reported results with cemented Lubinus cups and uncemented Furlong stems, and they also pointed out the possibility of using the principle of reverse hybrid arthroplasty. We are not aware of any other reports on the reverse hybrid method.

In a reverse hybrid THR, an uncemented stem and a modular head are most often combined with a cemented cup of another name or from another company. Combining implants that are not designed to fit each other might theoretically lead to unexpected complications such as increased wear, loosening, or dislocation. This concern was raised by the NAR already in their report from 2005 ([@CIT0020]). As the use of reverse hybrids is increasing, we decided to evaluate the short- to medium-term results with this concept and to compare them with those from all-cemented THRs, using data from the NAR.

Patients and methods {#ss2}
====================

The NAR was established in September 1987 ([@CIT0011]). Data on primary and revision THR surgery are collected, and the patients are followed prospectively until revision, death, or emigration. The unique identification number assigned to each resident of Norway makes it possible to link the primary operation to revision surgery and to the National Population Register, which provides information on death or emigration. Completeness of registration is high for total hip replacement, for both primary and revision surgery ([@CIT0002], [@CIT0006], [@CIT0016]).

From September 1, 1987 through December 31, 2009, 124,759 primary THRs were registered. Of these, 6,630 cases involved reverse hybrid THR. 15 different cups and 13 different femoral stems had been used for these reverse hybrids. Since reverse hybrid THR has mainly been used during the last decade, we included only operations performed after December 31, 1999. This gave 6,485 primary operations. We included only the combinations of cup and stem for which there had been more than 100 procedures since 2005. Thus, 3,963 operations in 3,630 patients were included ([Figure 1](#F1){ref-type="fig"}) for survival estimation at 5 and 7 years, involving 9 implant combinations (cup/stem) ([Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). In these implant combinations, all cups were made from conventional ultra-high-molecular-weight polyethylene (UHMWPE).

![Flowchart of the study.](ORT-0300-9734-082-639_g001){#F1}

###### 

Breakdown of numbers of different combinations of prosthesis components in the reverse hybrid group during the study period

  Combination of cup and stem (reverse hybrid)                                                          
  ---------------------------------------------- ------ ----- ----- ----- ----- ----- ----- ----- ----- ------
  2000                                           38     3     3     6     1     6     0     0     0     57
  2001                                           43     22    14    13    2     4     0     0     0     98
  2002                                           45     46    6     37    3     7     0     0     0     144
  2003                                           61     50    9     55    8     2     61    0     0     246
  2004                                           83     72    14    63    16    9     50    12    0     319
  2005                                           178    79    39    69    10    5     61    37    34    512
  2006                                           269    82    66    18    11    14    0     29    49    538
  2007                                           365    75    98    26    18    34    0     18    29    663
  2008                                           362    113   157   5     28    13    0     16    0     694
  2009                                           318    180   121   3     45    11    0     14    0     692
  Total                                          1762   722   527   295   142   105   172   126   112   3963

**^a^** Full brand name: Reflection Cemented All-Poly.

###### 

Comparison of different combinations of prosthesis components in the reverse hybrid group

  Brand name cup/stem                             Manufacturer cup/stem                                    N      Revisions   Median follow-up (range)   Mean age (min--max)   \% \< 60 year   \% male   No. of hospitals (max % at hospital)
  ----------------------------------------------- -------------------------------------------------------- ------ ----------- -------------------------- --------------------- --------------- --------- --------------------------------------
  Elite/Corail                                    Landos Depuy/Depuy                                       1762   40          2.6 (0--10)                60 (21--92)           48              40        15 (34%)
  Titan/Corail                                    Landos Depuy/Depuy                                       722    21          3.0 (0--9.8)               63 (27--91)           36              36        11 (34%)
  Kronos/Corail                                   Landos Depuy/Depuy                                       527    12          1.8 (0--9.7)               63 (20--92)           33              32        4 (83%)
  RPE **[^a^](#T2-N1){ref-type="fn"}**/Corail     Smith & Nephew/Depuy                                     295    17          5.6 (0--9.9)               58 (18--90)           58              37        11 (35%)
  Exeter/ ABG II                                  Stryker **[^b^](#T2-N2){ref-type="fn"}**/Stryker         172    6           5.4 (1.4--7.0)             73 (50--88)           2               37        2 (82%)
  RPE **[^a^](#T2-N1){ref-type="fn"}**/Hactiv     Smith & Nephew/Scanos **[^c^](#T2-N3){ref-type="fn"}**   126    5           3.6 (0--5.6)               64 (19--91)           38              37        2 (97%)
  Exeter/Corail                                   Stryker **[^b^](#T2-N2){ref-type="fn"}**/Depuy           142    2           1.9 (0--9.9)               64 (19--87)           35              18        5 (67%)
  Charnley/Corail                                 Depuy/Depuy                                              105    2           2.8 (0.4--9.9)             58 (21--86)           61              21        14 (46%)
  RPE **[^a^](#T2-N1){ref-type="fn"}**/Taperloc   Smith & Nephew/Biomet                                    112    3           3.8 (2.5--4.7)             61 (40--82)           36              33        1 (100%)

**^a^** Full brand name: Reflection Cemented All-Poly.

**^b^** Full brand name: Stryker, Osteonics, Howmedica

**^c^** Full brand name: Scanos Evolutis

From the register, we extracted information on the brand(s) of the components, the diameter and the material of the femoral heads, the diagnosis, the name of the hospital, the surgical approach to the hip, and reasons for revision surgery. We estimated survival at 3, 5, and 7 years for the total material with any revision as the endpoint. Further subgroup analyses included survival at 3, 5, and 7 years in patients less than 60 years of age, with any revision as endpoint. Furthermore, we compared reverse hybrid THR to cemented THR for the total material, with deep infection, dislocation, aseptically loosened stem, and aseptically loosened cup as endpoint in the same period.

We compared the results to the 10 most commonly used cemented cup/stem combinations in the study period. These cemented implants and the cups in the reverse hybrid group have been described by [@CIT0007] ([Table 3](#T3){ref-type="table"}). Details of the stems in the present study are given in [Table 4](#T4){ref-type="table"}. We excluded patients operated with CMW cement, due to the poor results described by others after use of this cement ([@CIT0012], [@CIT0005]).

###### 

Cup/stem combinations in the cemented group. These have been thoroughly described by [@CIT0007]

                             Manufacturer                    Number of prostheses
  -------------------------- ------------------------------- ----------------------
  Charnley/Charnley          Depuy                           12,192
  Exeter/Exeter              Stryker, Osteonics, Howmedica   6,419
  Reflection PE/Spectron     Smith & Nephew                  8,618
  Titan/Titan                Landos, Depuy                   2,736
  Spectron/ITH               Smith & Nephew                  162
  Link IP/Lubinus SP(I,II)   Waldemar Link                   2,203
  Contemporary/Exeter        Stryker, Osteonics, Howmedica   2,707
  Kronos/Titan               Landos, Depuy                   1,073
  Elite/Titan                Depuy/Landos Depuy              1,139
  Reflection/ITH             Smith & Nephew                  417

###### 

Details of the characteristics of the uncemented femoral stems used in the reverse hybrid group. 97% had HA coating

  Stem       Material   Shape               Surface                                                   Thickness of HA   Company
  ---------- ---------- ------------------- --------------------------------------------------------- ----------------- ----------
  Corail     Ti6A14V    Straight, tapered   Fully HA-coated                                           155 µm            DePuy
  ABG II     Ti alloy   Anatomic            HA-coated proximal, polished distally                     50 µm             Stryker
  Hactiv     Ti6A14V    Straight, tapered   Fully HA-coated                                           155 µm            Evolutis
  Taperloc   Ti6A14V    Straight, tapered   Without HA in this study, proximal plasma spray coating                     Biomet

Statistics {#ss3}
----------

Risk Ratio (RR) with 95% confidence interval (CI) was estimated using Cox regression analyses, with adjustments for age (\< 50, 50--59, 60--69, 70--79 and \> 80), sex, and diagnosis (osteoarthritis (OA), inflammatory arthritis, and others). We used plots with scaled Schoenfeld residuals for each covariate to test that the Cox proportional hazard model was fulfilled. The Kaplan-Meier method was used for estimation of survival probabilities for the prostheses, with 95% confidence interval (CI). [@CIT0021] have discussed statistical analysis regarding arthroplasty register data and found a negligible effect on survival estimates including bilateral hips. We therefore included bilateral hips. When less than 20 hips remained at risk, survival probabilities were not calculated. Median follow-up was calculated using the reverse Kaplan-Meier method. We used chi-squared test to test for binary outcomes between study groups, and the non-parametric Mann-Whitney test was used to determine whether the distribution of medians was different between study groups. All p-values less than 0.05 were considered to be statistically significant. We used the statistical software packages SPSS (SPSS 17.0 for Windows) and R (version 2.8.1; <http://www.R-project.org>).

Results {#ss4}
=======

The mean age was lower in the reverse hybrid group than in the cemented group: 61 (18--92) years as opposed to 73 (16--98) years. The proportion of males was higher in the reverse hybrid group than in the cemented group (36% vs. 29%). In addition, 9% of patients were below 60 years of age in the cemented group and the corresponding proportion in the reverse hybrid group was 42%. Furthermore, there were significant differences regarding diagnosis, age, and sex ([Table 5](#T5){ref-type="table"}). In the total material, median follow-up was 2.9 (0--10) years in the reverse hybrid group and 4.7 (0--10) years in the cemented group. For patients aged less than 60 years, the median follow-up was 3.4 (0--10) years for reverse hybrid and 5.2 (0--10) years for cemented ([Table 5](#T5){ref-type="table"}).

###### 

Comparison of demographic data for cemented and reverse hybrid THRs, both for total material and for patients aged \< 60 years. Comparison of survival (in %) and relative risk (RR) of revision for cemented and reverse hybrid THRs, with all revisions as endpoint, for total material and for patients aged \< 60 years

                                                Total material      Age \< 60 years                                                                                         
  --------------------------------------------- ------------------- ------------------- ------------------------------------------- ------------------- ------------------- -------------------------------------------
  n                                             37,666              3,963                                                           3,480               1,647               
  Revisions                                     1,140               108                                                             135                 41                  
  Median follow-up (range)                      4.7 (0--10)         2.9 (0--10)         \< 0.001 **[^b^](#T5-N2){ref-type="fn"}**   5.2 (0--10)         3.4 (0--10)         \< 0.001 **[^b^](#T5-N2){ref-type="fn"}**
  Mean age (min--max)                           73 (16--98)         61 (18--92)         \< 0.001 **[^b^](#T5-N2){ref-type="fn"}**   54 (16--60)         52 (18--60)         \< 0.001 **[^b^](#T5-N2){ref-type="fn"}**
  \% \< 60 years                                9                   42                  \< 0.001 **[^a^](#T5-N1){ref-type="fn"}**   100                 100                 
  \% male                                       29                  36                  \< 0.001 **[^a^](#T5-N1){ref-type="fn"}**   36                  39                  0.06 **[^a^](#T5-N1){ref-type="fn"}**
  Deceased                                      5,928 (15.7%)       104 (2.6%)                                                      229 (6.6%)          25 (1.5%)           
  Emigrated                                     58 (0.2%)           8 (0.2%)                                                        21 (0.6%)           4 (0.4%)            
  Missing                                       2                   0                                                               0                   0                   
  Alive                                         31,678 (84.1%)      3,851 (97.2%)                                                   3,230 (92.8%)       1,618 (98.2%)       
  Diagnosis                                                                             \< 0.001 **[^a^](#T5-N1){ref-type="fn"}**                                           \< 0.001 **[^a^](#T5-N1){ref-type="fn"}**
   Osteoarthritis                               78.6%               70.9%                                                           56.6%               55.9%               
   RA/Inflammatory                              3.3%                4.2%                                                            8.0%                6.0%                
   Sequelae hip fracture                        8.9%                5.2%                                                            7.1%                4.8%                
   Dysplasia                                    4.3%                11.6%                                                           16.5%               20.4%               
   Perthes\'                                    0.6%                2.2%                                                            3.1%                4.5%                
   Other                                        4.4%                5.9%                                                            8.7%                8.4%                
  3-year survival (95%CI)                       97.9 (97.7--98.0)   97.7 (97.2--98.2)                                               98.0 (97.5--98.5)   98.3 (97.7--99.0)   
  5-year survival (95%CI)                       97.0 (96.8--97.2)   96.7 (96.0--97.4)                                               96.7 (96.0--97.3)   97.5 (96.6--98.5)   
  7-year survival (95%CI)                       96.0 (95.7--96.2)   95.6 (94.4--96.7)                                               94.9 (94.0--95.9)   96.2 (94.6--97.8)   
  RR **[^c^](#T5-N3){ref-type="fn"}** (95%CI)   1 (Reference)       1.1 (0.9--1.4)      0.3                                         1 (Reference)       0.9 (0.6--1.3)      0.5

**^a^** Chi-squared test.

**^b^** Non-parametric Mann-Whitney.

**^c^** RR adjusted for age, sex, and diagnosis.

There was no statistically significant difference in implant survival between cemented and reverse hybrid THRs when the endpoint was any revision. This was also found in analyses of cases less than 60 years of age ([Figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}, [Table 5](#T5){ref-type="table"}). In subanalyses of the total material using the endpoints revision due to deep infection, dislocation, aseptically loosened stem, and aseptically loosened cup, no statistically significant differences between cemented and reverse hybrid THRs were found.

![Cox survival curves. Endpoint was any revision of the implant for the total material. Adjusted for age, sex, and diagnosis. Age: \< 50, 50--59, 60--69, 70--79 and \> 80. Diagnosis: OA, RA/inflammatory, or other.](ORT-0300-9734-082-639_g002){#F2}

![Cox survival curves. Endpoint was any revision of the implant. Age \< 60 years. Adjustment for age, sex, and diagnosis. Age: \<50, 50--60. Diagnosis: OA, RA/inflammatory, or other.](ORT-0300-9734-082-639_g003){#F3}

The reverse hybrids had a 3.6 times higher risk of revision for periprosthetic femoral fracture compared to the cemented implants (CI: 1.9--6.9; p \< 0.001). The survival was 99.85% (99.8--99.9) and 99.6% (99.3--99.9), respectively, at 5 years using this endpoint.

We performed analyses of the different cup/stem combinations in the reverse hybrid group with all revisions as the endpoint at 3 and 5 years. No statistically significant differences were found. Reflection PE/Hactiv and Reflection PE/Taperloc had less than 20 hips left at risk at 5 years; thus, 5-year survival of these combinations could not be estimated.

In the reverse hybrid group, 3,832 of the 3,963 prostheses had a femoral head with a diameter of 28 mm. 2,467 heads were made of alumina and 1,286 heads were made of cobalt chromium. In these 2 groups, all head sizes were included.

Among the different groups of reverse hybrid combinations, we noted differences in age, in median follow--up time, and in the male/female ratio. The ReflectionPE/Taperloc combination has been used since 2005, but maximum follow-up for this group only reached 4.7 years. All the other groups of reverse hybrid combinations had a maximum follow-up of more than 5 years ([Table 2](#T2){ref-type="table"}).

Discussion {#ss5}
==========

The use of reverse hybrids has increased in Norway and Sweden during the last decade. Before 2000, few reverse hybrid operations were performed each year, and with many different combinations of components. In this pre-2000 period, we believe that in some instances failure to achieve solid fixation of an uncemented cup made the surgeon convert to a cemented cup. Since the year 2000, the reverse hybrid concept has been used more systematically in Norway and the number of implanted primary reverse hybrids has increased from 90 in the year 2000 to 1,735 in 2009. In Sweden, the number of hybrid THRs has declined and the total number of reverse hybrids has increased ([@CIT0024]). This increase in popularity called for the evaluation of medium-term results using this method.

Comparing the reverse hybrid group with the 10 most used cemented THRs, we found similar implant survival with 0--10 years of follow-up. The only differences found were for subanalyses on femoral fractures, but the difference in survival at 5 years with this endpoint was only 0.25% and 5-year survival exceeded 99% for both groups. This indicates that periprosthetic femoral fractures are an infrequent complication leading to revision surgery.

For the total material, the proportion of males was higher and the mean age was lower in the reverse hybrid group than in the cemented group. We had no scoring for activity level, and there could be a bias in comparing high-demand young men to a group with low-demand elderly women. However, when we limited analyses to patients less than 60 years of age, the groups were much more similar to each other. The median follow-up for total material and for cases below 60 years differed significantly between study groups, and with short follow-up it may therefore be difficult to uncover differences between these 2 concepts.

We found similar risk of deep infection with reverse hybrid and cemented THR. Only revisions that included removal or exchange of parts or the whole implant were reported to the register. Thus, soft tissue revisions without the exchange of prosthetic parts were not reported to the NAR. For the period 2003--2007 and using data from the NAR, [@CIT0003] found a statistically significant difference in numbers of revisions due to deep infection with inferior results for uncemented THR compared to cemented THR. One explanation for our finding is that antibiotic in the cement in reverse hybrids may protect against deep infection ([@CIT0004]).

In the present study, 97% of the stems had HA coating and in the medium term we found results comparable to those for cemented THR ([Table 4](#T4){ref-type="table"}). In 2002, the NAR reported inferior results for 2 types of HA-coated cups as compared to cemented Charnley cups ([@CIT0015]). In [@CIT0017], Lazarinis et al. reported increased risk of revision of acetabular cups coated with HA, and in 2009 Stilling et al. reported inferior results for an HA-coated cup compared to those for a non HA-coated cup at 15 years. Concerns have been raised about third body wear induced by HA from HA-coated implants. [@CIT0022] discussed whether thick HA coatings may delaminate, and suggested that thick HA coatings may be a reservoir for HA particles. Wear and wear-related problems may appear several years after the primary procedure. Studies with large numbers and long follow-up are thus necessary in order to be able to conclude whether the performance of cup implants is influenced by the stem having an HA coating. Regarding this problem, randomized controlled trials measuring wear with precise methods are important, but registry studies collecting a large amount of data on prostheses may also reveal differences between HA-coated implants and those without any HA coating.

In the NAR, femoral fractures are reported if they require revision surgery. We found a higher risk of revision for periprosthetic femoral fracture in the reverse hybrids than in the all-cemented THRs. Although it was more common with uncemented stems, periprosthetic femoral fracture was uncommon in both groups. [@CIT0009] found in a study from the Swedish Arthroplasty Register that uncemented stems were more frequently revised due to periprosthetic fracture than cemented stems during the first 2 postoperative years.

We used the Kaplan-Meier method to estimate prosthesis survival, censoring death and emigration. Both death and emigration are competing risks regarding revision. In a study from the Australian Orthopaedic Association National Joint Replacement Registry, [@CIT0008] found that the Kaplan-Meier method overestimated the risk of revision compared to a method called the cumulative incidence function. The latter method uses competing risk methods in the analyses. With a short- to medium-term follow-up and a rather low incidence of death, we assumed that the Kaplan-Meier method would be appropriate to use in this study.

Regarding revision due to deep infection, dislocation, aseptically loosened stem, and aseptically loosened cup, we did not find any statistically significant difference between cemented and reverse hybrid THRs. In planning the study, we aimed to do subanalyses with the endpoints revision due to deep infection, dislocation, aseptically loosened stem, and aseptically loosened cup for the different combinations of cup/stem (different brands) in the reverse hybrid group. We found that the number of revisions and the number of procedures in some groups were quite small ([Table 2](#T2){ref-type="table"}). Thus, 1 single revision would have a large effect on the survival calculations for certain implant combinations. Although our register has a high completeness of data, we do not know for certain that all revisions of the primary THRs included were reported to the register. 1 or 2 missing revisions in 1 study group may offset the results quite dramatically when the groups are small. Furthermore, the accuracy of registry results is not known; the surgeon may type the data into the wrong box on the form, or the register may enter wrong data into the database. It is therefore difficult to make conclusions about the performance of the different components used in the reverse hybrid group. Subtle differences between study groups, if found, should be interpreted with caution---even if they are statistically significant. Factors other than the implant itself, such as surgical technique, revision policy, incorrect registration, or unknown patient factors may bias the results.

In summary, we found no statistically significant differences in survival between reverse hybrid and all-cemented THRs in this population-based registry study. Both groups performed well, with 95--96% survival after up to 7 years of follow-up. Thus, there were no early signs of warning against the reverse hybrid method according to our findings. Due to the small number of revisions in the present study, we cannot make any conclusions regarding the results for the different cup/stem combinations of reverse hybrid THR. With a short- to medium-term follow--up, it appears that the reverse hybrid method might be a promising alternative in THR surgery using UHMWPE. We emphasize that long-term follow-up will be required to evaluate whether the concept has any advantage over all-cemented THR.
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